Clinical Trial Detail

NCT ID NCT03031691
Title A Study of Brontictuzumab With Chemotherapy for Subjects With Previously Treated Metastatic Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements no
Sponsors OncoMed Pharmaceuticals, Inc.
Indications

colorectal cancer

Therapies

Brontictuzumab + Trifluridine

Age Groups: adult senior

No variant requirements are available.